Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Shares Outstanding (2016 - 2025)

IGC Pharma (IGC) has disclosed Shares Outstanding for 2 consecutive years, with $39.6 million as the latest value for Q4 2019.

  • On a quarterly basis, Shares Outstanding changed 0.04% to $39.6 million in Q4 2019 year-over-year; TTM through Dec 2019 was $39.6 million, a 0.04% change, with the full-year FY2019 number at $39.5 million, up 28.4% from a year prior.
  • Shares Outstanding was $39.6 million for Q4 2019 at IGC Pharma, roughly flat from $39.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $39.6 million in Q4 2018 to a low of $30.8 million in Q1 2018.